Drug Clinical Trials List

Share page

Display 541 - 550 from 730
Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
AfME Registry on GastroIntestinal Stromal Tumors (GIST) – A Retrospective Patients’ Profile Description and Evaluation of the Use of Tyrosine Kinase Inhibitors Africa Middle East Cancer Intergroup (AMCI) Ongoing - 4 WI210066 King Fahad Medical City (Riyadh)
Post-Authorization Safety Reporting Program of Canagliflozin-based Therapy in Patients With Type 2 Diabetes in Saudi Arabia Janssen-Cilag International NV Ongoing canagliflozin 4 28431754DI Specialized Medical Center (Riyadh), Dr. Soliman Fakeeh Hospital (Jeddah), International Medical Center (Jeddah), Dallah Hospital (Riyadh), Almana Hospital (Jubail), Almouasa Hospital (Qatif), Dr. Sulaiman Al-Habib Medical Group Olaya (Riyadh), Dr. Sulaiman Al-Habib Medical Group Rayan (Riyadh), Saudi German Hospital (Jeddah)
Clinical Effectiveness and Cost Implications of Patients Switching from Oral Antipsychotics to Long‑Acting Injectable Antipsychotics in the Treatment of Schizophrenia Janssen-Cilag International NV Ongoing Consta 4 RRA-19315 Alamal Complex for mental health (Riyadh), King Fahad University Hospital (Al-Khobar)
The Impact of Tigecycline Use on Fibrinogen Level in Post Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Patients. A Randomized Controlled Study King Faisal Specialist Hospital & Research Center Ongoing Tigecycline 4 RAC#216103 King Faisal Specialist Hospital and Research Center (Riyadh)
Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): A Randomized Controlled Clinical Trial Sunnybrook Health Sience Center / KAIMRC Ongoing All SFDA already registered Antibiotics 4 CT 15/022 King Abdulaziz Medical City NG (Riyadh)
ChaRactErization of patients following aCute venous thrOmboembolism (VTE) and assessment of safety and effectiveness of dabigatran etexilate (DE) in the tReatment and secondarY prevention of acute deep vein thrombosis (DVT) and pulmonary embolism (PE) in comparison to vitamin K antagonist (VKA) in routine clinical practice - RE-COVERY DVT/PE Boehringer Ingelheim Ongoing Dabigatran etexilate 4 1160.188 King Salman Bin AbdulAziz Hospital
Forxiga (dapagliflozin) Post Authorization Safety Study AstraZeneca Ongoing Forxiga 4 D1690R0003 King Khalid University Hospital (Riyadh), Taibah University College of Medicine, Dr. Sulaiman Al-Habib Medical Group (Riyadh), Specialized Medical Center (Riyadh), International Medical Center (Jeddah), Dallah Hospital (Riyadh), King Abdulaziz University Hospital (Jeddah)
A Multicenter, prospective, non-interventional study to assess Adherence to treatment for patIeNts with Relapsing Multiple Sclerosis (RMS) who are prescribed subcutaneous (sc) interferon beta-1a Merck Serono Ongoing Interferon Beta-1 a (Rebif) 4 MS200136_0 King Fahad Specialist Hospital (Dammam), King Khalid University Hospital (Riyadh), King Fahad University Hospital (Al-Khobar), King Faisal Specialist Hospital and Research Center (Jeddah)
"CAIN457A3404-REALIAA non-interventional, prospective 12-months study to characterize the REAL-life effectiveness and treatment patterns of SecukInumab and current standard of care inpatient with chronic plaque psoriAsis eligible for systemic treatment in the Asia-Pacific and Middle East regions" Novartis Ongoing Cosyntex 4 IN457A3404 King Khalid University Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah)
Does the Addition of Proton Pump Inhibitors to Continuous Enteral Feeding Provide Added Protection Against Upper GI Bleeding in Acutely Ill Patients KAIMRC Ongoing Esmoprozol 4 RC15/079 King Abdulaziz Medical City NG (Riyadh)


هل استفدت من ما هو مقدم في هذه الصفحة؟
0 من الزوار ردوا بنعم من أصل0 مشاركة
السبب
السبب